Anavex Life Sciences Corp (AVXL)

[nidan7500]

I am absolutely certain that Roche is interested in partnering with or buying Anavex Life Sciences or licensing Blarcamesine from Anavex.

I have heard and believe that JNJ and Pfizer among other big Pharma are also interested in Anavex Life Sciences.

Happy new year and GOD bless,

Agree. If AVXL presents the case evidence which clearly demonstrates efficacy w/o threats of AE's (as far as we have seen) or infusion requirements w/known AE possibility (based on trials history) then it is a slam dunk for the FDA. (FDA are off the hook politically w/association and BP) They (FDA) cannot lose . AD patients(families) have the choice to use the AVXL less expensive treatment w/very low-(no) risk of AE's or use the other option(s)...but, FDA do need to say..."do not say we did not warn you against possible serious AE's and much higher costs...it's your call", when refer to A2-73 treatments.

In other words A2-73 is the clear AD treatment winner if you are in the FDA and are serious about doing your job. (IMO)